תוצאות חיפוש - Giuseppe Procopio

Refine Results
  1. 1
    Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib

    Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib מאת G. Mickisch, M. Gore, Bernard Escudier, Giuseppe Procopio, Stefan Walzer, Mark Nuijten

    יצא לאור 2009
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  2. 2
    Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up מאת Chris Parker, Elena Castro, Karim Fizazi, Axel Heidenreich, Piet Ost, Giuseppe Procopio, Bertrand Tombal, Silke Gillessen

    יצא לאור 2020
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  3. 3
    Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy

    Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy מאת Roberto Iacovelli, Antonella Palazzo, Giuseppe Procopio, Matteo Santoni, Patrizia Trenta, Angelina De Benedetto, Silvia Mezi, Enrico Cortesi

    יצא לאור 2013
    קבל טקסט מלא
    Revisão
    הוספה למועדפים
    שמור ב:
  4. 4
    ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma

    ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma מאת Thomas Powles, Laurence Albigès, Axel Bex, Viktor Grünwald, Camillo Porta, Giuseppe Procopio, Manuela Schmidinger, Cristina Suárez, Guillermo de Velasco

    יצא לאור 2021
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  5. 5
    Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial

    Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial מאת Giuseppe Procopio, Elena Verzoni, Sergio Bracarda, Serafino Ricci, Cosimo Sacco, Laura Ridolfi, Camillo Porta, Rosalba Miceli, Nicoletta Zilembo, Emilio Bajetta

    יצא לאור 2011
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  6. 6
    5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors

    5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors מאת Emilio Bajetta, Lorenza Rimassa, Carlo Carnaghi, Ettore Seregni, Leonardo Ferrari, Maria Di Bartolomeo, Enrico Regalia, Antonio Cassata, Giuseppe Procopio, Luigi Mariani

    יצא לאור 1998
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  7. 7
    Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis

    Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis מאת Giuseppe Procopio, Joaquim Bellmunt, Janice P. Dutcher, Sergio Bracarda, Jennifer J. Knox, Andreas Brueckner, István Molnár, Bernard Escudier, Thomas E. Hutson

    יצא לאור 2013
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  8. 8
    Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer

    Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer מאת Alessandra Raimondi, Pierangela Sepe, Emma Zattarin, Alessia Mennitto, Marco Stellato, Mélanie Claps, Valentina Guadalupi, Elena Verzoni, Filippo de Braud, Giuseppe Procopio

    יצא לאור 2020
    קבל טקסט מלא קבל טקסט מלא
    Revisão
    הוספה למועדפים
    שמור ב:
  9. 9
    Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer in Older Women

    Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer in Older Women מאת Emilio Bajetta, Giuseppe Procopio, Luigi Celio, Luca Gattinoni, S. Della Torre, Luigi Mariani, Laura Catena, Riccardo Ricotta, Raffaella Longarini, Nicoletta Zilembo, Roberto Buzzoni

    יצא לאור 2005
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  10. 10
    Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: An up-to-date review and meta-analysis of clinical trials

    Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: An up-to-date review and meta-analysis of clinical trials מאת Matteo Santoni, Alessandro Conti, Francesco Massari, Giorgio Arnaldi, Roberto Iacovelli, Mimma Rizzo, Ugo De Giorgi, Laura Trementino, Giuseppe Procopio, Giampaolo Tortora, Stefano Cascinu

    יצא לאור 2014
    קבל טקסט מלא קבל טקסט מלא
    Revisão
    הוספה למועדפים
    שמור ב:
  11. 11
    Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?

    Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? מאת Emilio Bajetta, Laura Catena, Giuseppe Procopio, E. Bichisao, L. Ferrari, S. Della Torre, Sara De Dosso, Silvia Iacobelli, Roberto Buzzoni, Luigi Mariani, J Rosai

    יצא לאור 2005
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  12. 12
    Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression

    Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression מאת Vera Cappelletti, Elena Verzoni, Raffaele Ratta, Marta Vismara, Marco Silvestri, Rosanna Montone, Patrizia Miodini, Carolina Reduzzi, Mélanie Claps, Pierangela Sepe, Maria Grazia Daidone, Giuseppe Procopio

    יצא לאור 2020
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  13. 13
    Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?

    Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage? מאת Alessia Mennitto, Veronica Huber, Raffaele Ratta, Pierangela Sepe, Filippo de Braud, Giuseppe Procopio, Valentina Guadalupi, Mélanie Claps, Marco Stellato, Elena Daveri, Licia Rivoltini, Elena Verzoni

    יצא לאור 2020
    קבל טקסט מלא קבל טקסט מלא
    Revisão
    הוספה למועדפים
    שמור ב:
  14. 14
    Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma

    Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma מאת Giuseppe Procopio, Pierangela Sepe, Mélanie Claps, Sebastiano Buti, Maurizio Colecchia, Patrizia Giannatempo, Valentina Guadalupi, Luigi Mariani, Luca Lalli, Giovanni Fucá, Filippo de Braud, Elena Verzoni

    יצא לאור 2022
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  15. 15
    nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives

    nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives מאת Alfredo Berruti, Sergio Bracarda, Orazio Caffo, Enrico Cortesi, Rolando Maria D’Angelillo, Marzia Del Re, Gaetano Facchini, Giovanni Pappagallo, Giuseppe Procopio, Roberto Sabbatini, Daniele Santini

    יצא לאור 2023
    קבל טקסט מלא
    Revisão
    הוספה למועדפים
    שמור ב:
  16. 16
    Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

    Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours מאת Emilio Bajetta, L. Ferrari, Giuseppe Procopio, Laura Catena, Erminia Ferrario, Antonia Martinetti, Maria Di Bartolomeo, Roberto Buzzoni, Luigi Celio, Milena Vitali, Elena Beretta, Ettore Seregni, Emilio Bombardieri

    יצא לאור 2002
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  17. 17
    Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings

    Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings מאת Jochaim Beck, Giuseppe Procopio, Emilio Bajetta, Ulrich Keilholz, Sylvie Négrier, Cezary Szczylik, Carsten Bokemeyer, Sergio Bracarda, D. J. Richel, Michael Staehler, U.P. Strauss, Sabine Mersmann, K. Burock, Bernard Escudier

    יצא לאור 2011
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  18. 18
    Treatment Patterns in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated with Docetaxel (Doc)-Based Chemotherapy (Ctx): Proxima

    Treatment Patterns in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated with Docetaxel (Doc)-Based Chemotherapy (Ctx): Proxima מאת Hideyuki Akaza, Giuseppe Procopio, Choosak Pripatnanont, Gaetano Facchini, S. Fava, Duncan Wheatley, K.C. Leung, Mohammad Butt, A. Silva, Lucía Castillo, George Fountzilas, Simon Hitier, Evelyne Ecstein-Fraïsse, Samira Bensfia, Mustafa Özgüroğlu

    יצא לאור 2014
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  19. 19
    International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma – Meet-URO 33 study (REGAL study)

    International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma – Meet-URO 33 study (REGAL study) מאת Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, Sebastiano Buti, Giuseppe Procopio, Ugo De Giorgi, Sandro Pignata, Emanuele Naglieri, Marco Maruzzo, Giuseppe Luigi Banna, Pasquale Rescigno, Carlo Messina, Alvise Mattana, Umberto Basso, Davide Bimbatti

    יצא לאור 2024
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  20. 20
    Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer

    Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for... מאת Pier Vitale Nuzzo, Filippo Pederzoli, Calogero Saieva, Elisa Zanardi, Giuseppe Fotia, Andrea Malgeri, Sabrina Rossetti, Loana Valenca Bueno, Livia Andrade, Anna Patrikidou, Ricardo Pereira Mestre, Mikol Modesti, Sandro Pignata, Giuseppe Procopio, Giuseppe Fornarini, Ugo De Giorgi, Antonio Russo, Edoardo Francini

    יצא לאור 2023
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:

כלי חיפוש: